Literature DB >> 14628110

To: Looker HC, Fagot-Campagna A, Gunter EW et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46:766-772.

N Shukla, G D Angelini, Jamie Y Jeremy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14628110     DOI： 10.1007/s00125-003-1259-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Homocysteine and cardiovascular disease in diabetes mellitus.

Authors:  J Y Jeremy; N Shukla; G D Angelini
Journal:  Atherosclerosis       Date:  2002-10       Impact factor: 5.162

2.  Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease.

Authors:  M A Mansoor; C Bergmark; S J Haswell; I F Savage; P H Evans; R K Berge; A M Svardal; O Kristensen
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

3.  Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta.

Authors:  A M Emsley; J Y Jeremy; G N Gomes; G D Angelini; F Plane
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

4.  Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits.

Authors:  N Shukla; C S Thompson; G D Angelini; D P Mikhailidis; J Y Jeremy
Journal:  Diabetologia       Date:  2002-07-10       Impact factor: 10.122

5.  Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.

Authors:  H C Looker; A Fagot-Campagna; E W Gunter; C M Pfeiffer; K M Venkat Narayan; W C Knowler; R L Hanson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.